Retrospective Cohort Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Nov 28, 2018; 24(44): 5025-5033
Published online Nov 28, 2018. doi: 10.3748/wjg.v24.i44.5025
Table 1 Baseline characteristics of patients before and after inverse probability weighting n (%)
CharacteristicsUnweighted
Inverse probability weighting
All patients(n = 274)Urgent endoscopy(n = 173)Non-urgent endoscopy(n = 101)P valueAll patients(n = 272)Urgent endoscopy(n = 172)Non-urgent endoscopy(n = 100)P value
Demographics
Age (yr)58.05 ± 12.1057.62 ± 12.0958.77 ± 12.220.4558.14 ± 0.8558.17 ± 1.0358.10 ± 1.340.971
Sex (male)207 (75.5)128 (74.0)79 (78.2)0.469205 (74.6)127 (37.2)78 (37.4)0.956
Hepatocellular carcinoma149 (54.4)97 (56.1)52 (51.5)0.452148 (54.8)97 (27.8)51 (27.0)0.830
Prior variceal upper GI bleeding179 (65.3)110 (63.6)69 (68.3)0.511178 (65.7)109 (32.3)69 (33.5)0.713
Prior non-variceal upper GI bleeding8 (2.9)2 (1.2)6 (5.9)0.0558 (2.9)2 (1.4)6 (1.5)0.890
Initial hepatic encephalopathy< 0.0010.939
None241 (88.0)164 (94.8)77 (76.2)239 (88.6)163 (44.5)76 (44.4)
Grade I-II16 (5.8)5 (2.9)11 (10.9)16 (5.4)5 (2.5)11 (2.9)
Grade III-IV17 (6.2)4 (2.3)13 (12.9)17 (5.7)4 (2.6)13 (3.1)
Initial ascites0.0670.994
None111 (40.5)77 (44.5)34 (33.7)111 (41.1)77 (20.3)34 (20.8)
Mild77 (28.1)50 (28.9)27 (26.7)76 (29.4)49 (14.7)27 (14.7)
Moderate to severe86 (31.4)46 (26.6)40 (39.6)85 (29.5)46 (14.6)39 (14.9)
Etiology0.9850.930
HBV137 (50.0)86 (49.8)51 (50.5)136 (49.7)86 (24.4)50 (25.33)
HCV25 (9.1)16 (9.2)9 (8.9)25 (9.4)16 (5.4)9 (4.0)
Alcohol69 (25.2)43 (24.9)26 (25.7)68 (24.0)42 (12.3)26 (12.7)
Others43 (15.7)28 (16.2)15 (14.9)43 (16.0)28 (8.0)15 (8.0)
Vital signs
Systolic blood pressure (mm Hg)117 ± 26116 ± 26120 ± 260.221118 ± 2116 ± 2119 ± 30.408
Heart rate (beat/min)95 ± 1896 ± 1994 ± 170.55195 ± 195 ± 195 ± 20.827
Laboratory values
Hemoglobin9.2 ± 2.59.0 ± 2.59.6 ± 2.50.0449.1 ± 0.28.8 ± 0.29.3 ± 0.30.105
Platelet count (103/mL)117 + 79118 ± 78114 ± 800.701118 ± 5119 ± 6118 ± 80.917
Total bilirubin3.8 ± 5.83.5 ± 5.34.5 ± 6.50.1483.7 ± 0.43.6 ± 0.53.8 ± 0.50.817
Serum albumin2.9 ± 0.62.9 ± 0.62.9 ± 0.70.7023.0 ± 0.13.0 ± 0.14.0 ± 0.10.736
Prothromin time (INR)1.6 ± 1.81.4 ± 0.61.8 ± 2.90.0461.6 ± 0.11.5 ± 0.11.7 ± 0.20.157
Serum creatinine1.3 ± 1.51.4 ± 1.81.2 ± 1.00.241.2 ± 0.11.4 ± 0.11.1 ± 0.10.07
MELD score15.9 ± 7.815.4 ± 6.916.9 ± 9.20.11215.6 ± 0.515.6 ± 0.515.6 ± 0.80.964
Prognostic scores
Glasgow-Blatchford score9.1 ± 3.59.2 ± 3.39.1 ± 3.90.8189.3 ± 0.29.3 ± 0.39.3 ± 0.40.907
Rockall score3.9 ± 1.44.0 ± 1.43.6 ± 1.50.0213.4 ± 0.13.9 ± 0.13.9 ± 0.20.875
Endoscopy
Time to endoscopy, hours, median (IQR)12.7 (2.8-16.5)4.0 (2.1-6.8)19.5 (15.0-35.5)< 0.00112.5 (2.8-16.4)4.0 (2.2-6.8)19.5 (15.1-35.4)< 0.001